Article Details

With early-stage studies underway, Connect Biopharmaceuticals closes $55M round to advance ...

Retrieved on: 2019-01-02 21:40:56

Tags for this article:

Click the tags to see associated articles and topics

With early-stage studies underway, Connect Biopharmaceuticals closes $55M round to advance .... View article details on hiswai:

Excerpt

<div>The Suzhou-based biotech welcomed Advantech <b>Capital</b> as the lead investor in the Series B, which also featured familiar faces at <b>Qiming Venture</b> ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up